Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Cholinergic Antagonists: Pharmacological Actions
Cholinergic Antagonists: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Gabriela M Kuster1, Eugene Kotlyar, Mary K Rude
1Cardiovascular Medicine Section, Boston University Medical Center, Boston, Mass, USA.
矿物质皮质类受体对手eplerenone改善了生存率,并减轻了慢性压力过载的小鼠的不良心脏重塑. 这些发现突显了矿物质皮质类受体在心力衰竭进展中的作用.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: